Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Abdominal aortic aneurysm (AAA)

The ACR is seeking input on follow-up recommendations for abdominal aortic aneurysm

Specifically, the college wants additional input related to radiologic-recommended follow-up imaging of AAA, which is often discovered incidentally.

Thumbnail

State radiological society earns $20,000 grant to help fight ‘harmful’ scope-of-practice bills

The American College of Radiology Association announced the news Friday, with the money coming from its special fund established in 2021. 

FDA announces new Class I recall of troubled heart devices

The recall includes approximately 2,300 devices distributed to customers prior to July 24, 2017. There have been 44 complaints about this issue so far.

Healthcare fraud running rampant in South Florida

South Florida is “ground zero” for healthcare fraud, with companies popping up left and right ready to bilk Medicare and Medicaid for millions of dollars.

Pfizer recalls 4 million units of migraine medicine

The recalled products are not child resistant, posing a poison risk if the contents are swallowed by young children.

calculator taxes

Radiologists lobby for state bill that would ease tax burden of docs who treat certain patients

“Many private practice physicians and providers that I know are operating on smaller and smaller margins due to cuts in reimbursements," said radiologist Andrew Kayes, MD.

Thumbnail

Family of deceased patient awarded $880,000 after radiologist misses broken neck on CT scan

A jury sided with the estate of 76-year-old Ohioan Ronald Nielson, who was sent home without immobilization to protect his injury. 

Medicare money payment physician

These 27 drugs will be subject to Medicare rebates

The Medicare Prescription Drug Inflation Rebate Program will lower coinsurance for Medicare Part B beneficiaries for certain drugs, with savings between $2 and $390 per average dose starting April 1.